Table 2.
Dose-volume statistics for targets (average result).
| D max | D min | D mean | Fractional dose | V 95 (%) | |
|---|---|---|---|---|---|
| GTVnx | 78.24 | 66.37 | 72.62 | 2.25 | 99.4 |
| GTVln-L/R | 71.43 | 60.59 | 68.14 | 2.10 | 99.6 |
| CTV1 | 68.77 | 61.27 | 65.21 | 1.94 | 99.4 |
| CTV2 | 64.36 | 55.96 | 58.87 | 1.88 | 99.3 |
| CTVln | 54.19 | 50.04 | 51.42 | 1.82 | 99.3 |
GTVnx: gross target volume; GTVln-L/R: positive neck lymph nodes; CTV1: high-risk region of clinical tumor volume; CTV2: low- risk region of clinical tumor volume; CTVln: lymph node region of clinical tumor volume; V 95: percentage of volume receiving 95% of prescribed dose.